U.S. Stock Tracking – July 1, 2020

The company uses carbohydrates derived from low-carbon, renewable resources as raw materials and is developing renewable electricity and renewable natural gas for its production processes. Its product portfolio includes renewable biodiesel, isooctane, isobutanol, sustainable aviation fuel (SAF), isobutylene, ethanol, and animal feed. The company’s total revenue has declined year-on-year over the past two years; net losses have widened; and cash on hand has fallen by nearly half compared to the prior period. Its stock price peaked at RMB 2.91 on December 18, 2019, and hit a low of RMB 0.46 on July 1, 2020. On July 2, the stock opened 4.14% higher, rose to +5.17% amid volatility, then fell to −0.02%, closing down 2.02% below the previous day’s close. Turnover reached 44.68%. The company has no enterprise value. Twenty-nine institutions hold its shares, accounting for 10.89% of total shares outstanding. One analyst recommends holding, and another recommends buying—investors may monitor the stock but should proceed with caution. CLIR (ClearSign Technologies Corporation) Designs and develops products and technologies to enhance operational performance, energy efficiency, emissions reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States. Founded in 2008, the company changed its name in November 2019 and is headquartered in Seattle, Washington. Its dual plug-and-play technology provides direct burner replacement solutions for conventional refinery heaters. Over the past year, the company generated no total revenue; net losses narrowed year-on-year; cash on hand declined slightly quarter-on-quarter; and it holds a small amount of deferred revenue related to current operations. Its stock price hit a low of RMB 0.35 on March 20, 2020, and peaked at RMB 4.11 on June 17, 2020. On July 2, the stock opened 0.45% lower, fell further to −0.89%, then surged to +7.73% near market close, closing up 7.27% above the prior day’s close. Turnover was 2.81%. Market capitalization was slightly higher than enterprise value. Twenty-two institutions hold its shares, representing 23.99% of total shares outstanding. No analysts issued recommendations. Chasing gains carries risk; investors should proceed with caution. DNB (Dun & Bradstreet Holdings, Inc.) Provides business decision data and analytics across North America and globally. Founded in 1841, the company is headquartered in Short Hills, New Jersey. It offers financial and risk solutions, including: • D&B Finance Analytics: an online application providing real-time access to information, comprehensive monitoring, and portfolio analysis; • D&B Direct: an application programming interface (API) that delivers risk and financial data directly into enterprise applications for real-time credit decisions; • D&B Credit: enables small- and medium-sized enterprises (SMEs) to monitor and build their business credit profiles; • D&B Enterprise Risk Assessment Manager: automates and manages credit decisions and reporting; • Risk and compliance solutions, including: — D&B Compass: a cloud-based workflow management solution; — D&B Supplier Risk Manager: delivers insights to help certify, monitor, analyze, and mitigate risks across the supply chain; — D&B Onboard: provides comprehensive business insights to support global KYC/AML compliance and minimize financial, legal, and reputational risks; — D&B Beneficial Ownership: delivers risk intelligence on ultimate beneficial ownership; • Sales and marketing solutions, including: — D&B Optimizer: an integrated data management solution; — D&B Master Data: helps understand business relationships and leverage intelligence across the organization; — D&B Hoovers: a sales intelligence solution; — D&B Lattice: a customer data platform; — D&B Target Audience: helps clients reach the right audience with the right message; — D&B Visitor Intelligence: converts website visitors into leads; — D&B Direct: delivers valuable customer insights via API to CRM and marketing automation platforms, as well as on-demand business intelligence applications.

In-depth Market Research Report on China’s Bio-isobutylene Industry and Investment Outlook Assessment, 2024–2030

2.1.1 Sales Volume of Major Chinese Manufacturers of Bio-isobutylene (2020–2024) 2.1.2 Revenue of Major Chinese Manufacturers of Bio-isobutylene (2020–2024) 2.1.3 Revenue Ranking of Major Chinese Manufacturers of Bio-isobutylene in 2024 2.1.4 Prices of Bio-isobutylene Offered by Major Chinese Manufacturers (2020–2024) 2.2 Headquarters and Production Base Distribution of Major Chinese Manufacturers of Bio-isobutylene 2.3 Establishment Dates of Major Chinese Manufacturers of Bio-isobutylene and Commercial Launch Dates of Their Bio-isobutylene Products 2.4 Product Types and Applications of Bio-isobutylene Offered by Major Chinese Manufacturers 2.5 Industry Concentration and Competitive Landscape Analysis 2.5.1 Industry Concentration Analysis: Market Share of Top 5 Chinese Manufacturers in 2024 2.5.2 First-, Second-, and Third-Tier Chinese Manufacturers (Brands) of Bio-isobutylene and Their 2024 Market Shares 3. In-depth Analysis of Key Chinese Bio-isobutylene Enterprises 3.1 Global Bioenergies 3.1.1 Basic Information, Bio-isobutylene Production Bases, Headquarters, Competitors, and Market Position of Global Bioenergies 3.1.2 Specifications, Parameters, and Market Applications of Global Bioenergies’ Bio-isobutylene Products 3.1.3 Sales Volume, Revenue, Pricing, and Gross Margin of Global Bioenergies’ Bio-isobutylene in the Chinese Market (2020–2024) 3.1.4 Company Profile and Core Business Activities of Global Bioenergies 3.1.5 Latest Corporate Developments of Global Bioenergies 3.2 Gevo 3.2.1 Basic Information, Bio-isobutylene Production Bases, Headquarters, Competitors, and Market Position of Gevo 3.2.2 Specifications, Parameters, and Market Applications of Gevo’s Bio-isobutylene Products 3.2.3 Sales Volume, Revenue, Pricing, and Gross Margin of Gevo’s Bio-isobutylene in the Chinese Market (2020–2024) 3.2.4 Company Profile and Core Business Activities of Gevo 3.2.5 Latest Corporate Developments of Gevo 3.3 Butagaz 3.3.1 Basic Information, Bio-isobutylene Production Bases, Headquarters, Competitors, and Market Position of Butagaz 3.3.2 Specifications, Parameters, and Market Applications of Butagaz’s Bio-isobutylene Products 3.3.3 Sales Volume, Revenue, Pricing, and Gross Margin of Butagaz’s Bio-isobutylene in the Chinese Market (2020–2024) 3.3.4 Company Profile and Core Business Activities of Butagaz 3.3.5 Latest Corporate Developments of Butagaz 4. Analysis by Bio-isobutylene Product Type 4.1 Sales Volume of Different Bio-isobutylene Product Types in the Chinese Market (2020–2024) 4.1.1 Sales Volume and Market Share of Different Bio-isobutylene Product Types in the Chinese Market (2020–2024) 4.1.2 Forecasted Sales Volume of Different Bio-isobutylene Product Types in the Chinese Market (2024–2030) 4.2 Market Scale (Revenue) of Different Bio-isobutylene Product Types in the Chinese Market (2020–2024)

Gevo, Inc. Equity Earnings Report – HAN:ZGV3

Oct 12, 2026

Gevo Inc equity earnings are tracked on the Hannover Stock Exchange, though current market status shows no trades and limited financial detail availability.

TradingView

2026-04-02

Gevo Appoints Key Executive Team Members

2026-04-02

Insider Selling: Gevo (NASDAQ:GEVO) COO Sells $276,000 in Stock

2026-04-02

Andrew Shafer, Chief Customer Marketing & Brand Officer at Gevo, Sells $15k in Shares

2026-04-05

GEVO Valuation Analysis: Undervalued by Nearly 47%

2026-04-07

Gevo Inc Stock: Why Sustainable Fuels Make It a Long-Term Watch